Abstract: The present invention relates to methods for modulating angiogenesis, comprising administering to a subject, or cells or tissue derived therefrom: (i) one or more miRNA, or precursors or variants thereof, wherein at least one of said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to inhibit angiogenesis; or (ii) one or more antagonists of a miRNA, wherein said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to promote or induce angiogenesis. Also provided are methods of diagnosis of conditions associated with abnormal angiogenesis, or determining predisposition thereto. Suitable pharmaceutical compositions are also provided.
Type:
Grant
Filed:
June 4, 2010
Date of Patent:
April 26, 2016
Assignees:
CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY, UNIVERSITY OF SYDNEY, WENKART FOUNDATION
Inventors:
Jennifer Gamble, Mathew Vadas, Gregory Goodall, Jennifer Young
Abstract: The present invention relates to methods for modulating angiogenesis, comprising administering to a subject, or cells or tissue derived therefrom: (i) one or more miRNA, or precursors or variants thereof, wherein at least one of said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to inhibit angiogenesis; or (ii) one or more antagonists of a miRNA, wherein said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to promote or induce angiogenesis. Also provided are methods of diagnosis of conditions associated with abnormal angiogenesis, or determining predisposition thereto. Suitable pharmaceutical compositions are also provided.
Type:
Application
Filed:
June 4, 2010
Publication date:
August 2, 2012
Applicants:
Centenary Institute of Cancer Medicine and Cell Biology, Wenkart Foundation, Medvet Science Pty Ltd., University of Sydney
Inventors:
Jennifer Gamble, Mathew Vadas, Gregory Goodall, Jennifer Young